IP Library › Assignment 038646/0652
Patent Assignment
Reel/Frame 038646/0652

Change of Name

Recorded: 2016-05-19 Pages: 2
Assignor
Assignee
ARBUTUS BIOPHARMA CORPORATION
100-8900 GLENLYON PARKWAY, BURNABY, BRITISH COLUMBIA, V5J 5J8, CANADA
Covered Properties (3)
Lipid Formulation
Patent: 8,158,601 →
Application: 12/813,448 →
Publication: US 2010/0324120
Lipid Formulation
Patent: 8,802,644 →
Application: 13/357,856 →
Publication: US 2012/0183602
Lipid Formulations
Patent: 9,394,234 →
Application: 14/319,996 →
Publication: US 2015/0166465
Related Assignments (5)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Jun 28, 2013
From: CHEN, JIANXIN; ANSELL, STEVEN; AKINC, AKIN; DORKIN, JOSEPH ROBERT
To: ALNYLAM PHARMACEUTICALS, INC.
Reel/Frame 030706/0747 →
Assignment of Assignor's Interest Jul 31, 2014
From: ALNYLAM PHARMACEUTICALS, INC.
To: TEKMIRA PHARMACEUTICALS CORPORATION
Reel/Frame 033435/0126 →
Assignment of Assignor's Interest Jul 31, 2014
From: CHEN, JIANXIN; ANSELL, STEVEN; AKINC, AKIN; DORKIN, JOSEPH ROBERT
To: ALNYLAM PHARMACEUTICALS, INC.
Reel/Frame 033435/0159 →
Merger and Change of Name Jul 27, 2018
From: PROTIVA BIOTHERAPEUTICS INC.; ARBUTUS BIOPHARMA CORPORATION
To: ARBUTUS BIOPHARMA CORPORATION
Reel/Frame 046640/0764 →
Security Interest Oct 1, 2025
From: ALNYLAM PHARMACEUTICALS, INC.; SIRNA THERAPEUTICS, INC.
To: BANK OF AMERICA, N.A.
Reel/Frame 072996/0337 →